Method of detecting new cancer stem cell-like enrichment in development front assay (DFA)

Journal of Stem Cells

Volumn 9, Issue 4, 2014, Pages 235-242

  Saha, Arka ^a   Padhi, Swati Shree ^a   Roy, Shomereeta ^a   Banerjee, Birendranath ^a  

^a KIIT UNIVERSITY   (India)

Author keywords

And Stem cell enrichment; Cancer stem cells (CSC); Cell migration; Development front assay (DFA)

Indexed keywords

CELL SURFACE PROTEIN; ALDEHYDE DEHYDROGENASE ISOENZYME 1; CD44 PROTEIN, HUMAN; HERMES ANTIGEN; ISOENZYME; RETINAL DEHYDROGENASE;

ARTICLE; CANCER STEM CELL; CELL BEHAVIOR ASSAY; CELL DENSITY; CELL MIGRATION; CELL PROLIFERATION; CELL SUSPENSION; DEVELOPMENT FRONT ASSAY; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FLUORESCENCE; FLUORESCENCE MICROSCOPY; HCT116 CELL LINE; HUMAN; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; METASTASIS POTENTIAL; PROTEIN EXPRESSION; TUMOR CELL; BIOSYNTHESIS; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METASTASIS; PATHOLOGY; WOUND HEALING;

ANTIGENS, CD44; CELL MOVEMENT; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; ISOENZYMES; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; RETINAL DEHYDROGENASE; WOUND HEALING;

EID: 84930806185     PISSN: 15568539     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Wu X, Shen QT, Oristian DS et al. Skin stem cells orchestrate directional migration by regulating microtubule-ACF7 connections through GSK3B. Cell, 2011, 144: 341-352.
2. Pham PV, Nguyen ST, Phan NL-C et al. Roles of CD44 in stem cells and cancer stem cells.
3. Zahm JM, Kaplan H, Hérard AL et al. Cell migration and proliferation during the invitro wound repair of the respiratory epithelium. Cell Motil Cytoskeleton, 1997, 37(1): 33-43.
4. Karp JM, Leng Teo GS. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell, 2009, 4(3): 206-216.
5. Akram KM, Samad S, Spiteri MA, Forsyth NR. Mesenchymal stem cells promote alveolar epithelial cell wound repair invitro through distinct migratory and paracrine mechanisms. Respiratory Research, 2013, 14(9): 1-16.
6. Huang SP, Huang CH, Shyu JF, Lee HS, Chen SG, Chan JYH, Huang SM. Promotion of wound healing using adipose-derived stem cells in radiation ulcer of a rat model. Journal of Biomedical Science, 2013, 20(51): 1-10.
7. Safferling K, Sutterlin T, Westphal K, Ernst C, Breuhahn K, James M, Jager D, Halama N, Grabe N. Wound healing revised: A novel reepthelialization mechanism revealed by in vitro and in silico models. JCB, 2013, 203(4): 691-709.
8. Liang CC, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nature Protocols, 2007, 2(2): 329-333.
9. Lee A, Wu JC. Imaging of embryonic stem cell migration in vivo. Methods Mol Biol., 2011, 750: 101-114.
10. Zoller M. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer, 2011, 11: 254-267.
11. Hiraga T, Ito S, Nakamura H. Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility and hyaluronan production. Cancer Res, 2013, 73: 4112-4122.
12. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer, 2008, 8: 755-68.
13. Naor D, Wallach-Dayan SB, Zahalka MA, Sionov RV. Involvement of CD44, a molecule with a thousand faces, in cancer dissemination. Semin Cancer Biol, 2008, 18(4): 260-267.
14. Jaggupilli A, Elkord E. Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity. Clin Dev Immunol, 2012; 1-11.
15. Du L, Wang H, He L, Zhang J, Ni B, Wang X, Jin H, Cahuzac N, Mehrpour M, Lu Y, Chen Q. CD44 is of functional importance for colorectal cancer stem cells. Clin Cancer Res, 2008, 14(21): 6751-60.
16. Leung EL, Fiscus RR, Tung JW, Tin VP, Cheng LC, Sihoe AD, Fink LM, Ma Y, Wong MP. Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties. PLOS One, 2010, 5(11): 1-13.
17. Charafe-Jauffret E, Ginestier C, Iovino F, Tarpin C, Diebel M, Esterni B, Houvenaeghel G, Extra JM, Bertucci F, Jacquemier J, Xerri L, Dontu G, Stassi G, Xiao Y, Barsky SH, Birnbaum D, Viens P, Wicha MS. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res, 2010, 16(1): 45-55.
18. de Beça FF, Caetano P, Gerhard R, Alvarenga CA, Gomes M, Paredes J, Schmitt F. Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types. J Clin Pathol, 2013, 66(3): 187-91.
19. Jiang F, Qiu Q, Khanna A, Todd NW, Deepak J, Xing L, Wang H, Liu Z, Su Y, Stass SA, Katz RL. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res, 2009, 7(3): 330-8.
20. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell., 2007, 1(5): 555-67.
21. Moreb JS, Mona M, Chang LJ, Yeh YL, Amory J, Goldstein A. The role of aldehyde dehydrogenase isoenzymes in cancer cell proliferation, migration and drug resistance. Cancer Research, 2013, 73(8).
22. Naor D, Sionov RV, Ish-Shalom D. CD44: structure, function, and association with the malignant process. Adv Cancer Res., 1997, 71: 241-319.
23. Naor D, Nedvetzki S, Golan I, Melnik L, Faitelson Y. CD44 in cancer. Crit Rev Clin Lab Sci, 2002, 39: 527-79.
24. Nagata T, Sakakura C, Komiyama S, Miyashita A, Nishio M, Murayama Y, Komatsu S, Shiozaki A, Kuriu Y, Ikoma H, Nakanishi M, Ichikawa D, Fujiwara H, Okamoto K, Ochiai T, Kokuba Y, Sonoyama T, Otsuji E. Expression of cancer stem cell markers CD133 and CD44 in locoregional recurrence of rectal cancer. Anticancer Res. 2011, 31(2): 495-500.
25. Yu Q, Stamenkovic I. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev, 1999, 13: 35-48.
26. Ouhtit A, Abd Elmageed ZY, Abdraboh ME, Lioe TF, Raj MH. In vivo evidence for the role of CD44s in promoting breast cancer metastasis to the liver. Am J Pathol 2007, 171: 2033-9.
27. Brown RL, Reinke LM, Damerow MS, Perez D, Chodosh LA, Yang J, et al. CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. J Clin Invest, 2011, 121: 1064-74.
28. Sahlberg SH, Spiegelberg D, Glimelius B, Stenerlöw B, Nestor M. Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells. PLoS One., 2014, 9(4): e94621.
29. Raha D, Wilson TR, Peng J, Peterson D, Yue P, Evangelista M, Wilson C, Merchant M, Settleman J. The cancer stem cell marker aldehyde dehydrogenase is required to maintain a drug-tolerant tumor cell subpopulation. Cancer Res., 2014, 74(13): 3579-90.
30. Wang Q, Cui K, Espin-Garcia O, Cheng D, Qiu X, Chen Z, Moore M, Bristow RG, Xu W, Der S, Liu G. Resistance to bleomycin in cancer cell lines is characterized by prolonged doubling time, reduced DNA damage and evasion of G2/M arrest and apoptosis. PLoS One, 2013, 8(12): e82363.